Article History
Received: 1 August 2022
Revised: 7 November 2022
Accepted: 14 November 2022
First Online: 24 November 2022
Declarations
: The CHAT study protocol was approved by the Institutional Review Board of all sites participating in the study, specific for each site and recruitment procedures met local HIPAA rules. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants in the CHAT study or their caretakers.
: Dr. Magnusdottir is Medical Director of MyCardio LLC and has a partial ownership. SleepImage is the brand name of MyCardio LLC, a privately held entity. MyCardio LLC is a licensee of the CPC- algorithm, a method to phenotype sleep and sleep apnea, from the Beth Israel Deaconess Medical Center, Boston, MA, USA. Dr. Witmans has no conflict of interest. Mr. Hilmisson is a Director of Research & Development for MyCardio LLC and has no conflict of interest to declare.